{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T01:22:51Z","timestamp":1790558571571,"version":"4.1.0"},"reference-count":34,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2020,2,18]]},"DOI":"10.1001\/jama.2020.0150","type":"journal-article","created":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T16:47:34Z","timestamp":1582044454000},"page":"646","source":"Crossref","is-referenced-by-count":123,"title":["Association Between Genetically Proxied Inhibition of HMG-CoA Reductase and Epithelial Ovarian Cancer"],"prefix":"10.1001","volume":"323","author":[{"given":"James","family":"Yarmolinsky","sequence":"first","affiliation":[{"name":"MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom"},{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline J.","family":"Bull","sequence":"additional","affiliation":[{"name":"MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom"},{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom"},{"name":"School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma E.","family":"Vincent","sequence":"additional","affiliation":[{"name":"MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom"},{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom"},{"name":"School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Robinson","sequence":"additional","affiliation":[{"name":"MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom"},{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Walther","sequence":"additional","affiliation":[{"name":"Bristol Cancer Institute, University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George Davey","family":"Smith","sequence":"additional","affiliation":[{"name":"MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom"},{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah J.","family":"Lewis","sequence":"additional","affiliation":[{"name":"MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom"},{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline L.","family":"Relton","sequence":"additional","affiliation":[{"name":"MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom"},{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M.","family":"Martin","sequence":"additional","affiliation":[{"name":"MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom"},{"name":"Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom"},{"name":"National Institute for Health Research Bristol Biomedical Research Centre, University of Bristol, University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"4","key":"joi200003r1","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3322\/caac.21456","article-title":"Ovarian cancer statistics, 2018.","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"joi200003r2","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1001\/jama.2017.21421","article-title":"Screening for ovarian cancer: updated evidence report and systematic review for the US Preventive Services Task Force.","volume":"319","author":"Henderson","year":"2018","journal-title":"JAMA"},{"issue":"4","key":"joi200003r3","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1517\/14740331003662620","article-title":"Statin use and cancer risk: a comprehensive review.","volume":"9","author":"Boudreau","year":"2010","journal-title":"Expert Opin Drug Saf"},{"issue":"30","key":"joi200003r4","doi-asserted-by":"publisher","first-page":"47343","DOI":"10.18632\/oncotarget.v7i30","article-title":"Ovarian tumour growth is characterized by mevalonate pathway gene signature in an orthotopic, syngeneic model of epithelial ovarian cancer.","volume":"7","author":"Greenaway","year":"2016","journal-title":"Oncotarget"},{"issue":"20","key":"joi200003r5","doi-asserted-by":"publisher","first-page":"4652","DOI":"10.1158\/1078-0432.CCR-14-3368","article-title":"Mevalonate pathway antagonist suppresses formation of serous tubal intraepithelial carcinoma and ovarian carcinoma in mouse models.","volume":"21","author":"Kobayashi","year":"2015","journal-title":"Clin Cancer Res"},{"key":"joi200003r6","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/1471-2407-10-103","article-title":"Lovastatin induces apoptosis of ovarian cancer cells and synergizes with doxorubicin: potential therapeutic relevance.","volume":"10","author":"Martirosyan","year":"2010","journal-title":"BMC Cancer"},{"issue":"5","key":"joi200003r7","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1002\/ijc.v144.5","article-title":"Statin therapy and association with ovarian cancer risk in the New England Case Control (NEC) study.","volume":"144","author":"Akinwunmi","year":"2019","journal-title":"Int J Cancer"},{"issue":"3","key":"joi200003r8","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.ygyno.2014.04.007","article-title":"Effect of statin on risk of gynecologic cancers: a meta-analysis of observational studies and randomized controlled trials.","volume":"133","author":"Liu","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"9","key":"joi200003r9","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1158\/1055-9965.EPI-17-1177","article-title":"Causal inference in cancer epidemiology: what is the role of mendelian randomization?","volume":"27","author":"Yarmolinsky","year":"2018","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"joi200003r10","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/ng.3826","article-title":"Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.","volume":"49","author":"Phelan","year":"2017","journal-title":"Nat Genet"},{"issue":"11","key":"joi200003r11","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1038\/ng.2797","article-title":"Discovery and refinement of loci associated with lipid levels.","volume":"45","author":"Willer","year":"2013","journal-title":"Nat Genet"},{"issue":"8","key":"joi200003r12","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1002\/gepi.2017.41.issue-8","article-title":"Mendelian randomization with fine-mapped genetic data: choosing from large numbers of correlated instrumental variables.","volume":"41","author":"Burgess","year":"2017","journal-title":"Genet Epidemiol"},{"issue":"3","key":"joi200003r13","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/ije\/dyr036","article-title":"Avoiding bias from weak instruments in mendelian randomization studies.","volume":"40","author":"Burgess","year":"2011","journal-title":"Int J Epidemiol"},{"issue":"6","key":"joi200003r14","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.ajhg.2016.10.003","article-title":"Colocalization of GWAS and eQTL signals detects target genes.","volume":"99","author":"Hormozdiari","year":"2016","journal-title":"Am J Hum Genet"},{"issue":"11","key":"joi200003r15","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1038\/ng.3412","article-title":"Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair.","volume":"47","author":"Day","year":"2015","journal-title":"Nat Genet"},{"issue":"7538","key":"joi200003r16","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nature14177","article-title":"Genetic studies of body mass index yield new insights for obesity biology.","volume":"518","author":"Locke","year":"2015","journal-title":"Nature"},{"issue":"7520","key":"joi200003r17","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nature13545","article-title":"Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche.","volume":"514","author":"Perry","year":"2014","journal-title":"Nature"},{"issue":"5","key":"joi200003r18","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/ng.571","article-title":"Genome-wide meta-analyses identify multiple loci associated with smoking behavior.","volume":"42","author":"Tobacco","year":"2010","journal-title":"Nat Genet"},{"issue":"4","key":"joi200003r20","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1093\/aje\/kwu283","article-title":"Multivariable mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects.","volume":"181","author":"Burgess","year":"2015","journal-title":"Am J Epidemiol"},{"issue":"2","key":"joi200003r21","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression.","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"issue":"4","key":"joi200003r22","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.2016.40.issue-4","article-title":"Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator.","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"issue":"6","key":"joi200003r23","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1093\/ije\/dyx102","article-title":"Robust inference in summary data mendelian randomization via the zero modal pleiotropy assumption.","volume":"46","author":"Hartwig","year":"2017","journal-title":"Int J Epidemiol"},{"issue":"7414","key":"joi200003r24","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses.","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"1","key":"joi200003r25","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/bjc.2014.574","article-title":"Statin use and risk for ovarian cancer: a Danish nationwide case-control study.","volume":"112","author":"Baandrup","year":"2015","journal-title":"Br J Cancer"},{"issue":"4","key":"joi200003r26","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.tem.2007.12.004","article-title":"Do the cholesterol-lowering properties of statins affect cancer risk?","volume":"19","author":"Solomon","year":"2008","journal-title":"Trends Endocrinol Metab"},{"issue":"5","key":"joi200003r27","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0022-2275(20)42221-7","article-title":"Multivalent feedback regulation of HMG CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth.","volume":"21","author":"Brown","year":"1980","journal-title":"J Lipid Res"},{"issue":"14","key":"joi200003r28","doi-asserted-by":"publisher","first-page":"3951","DOI":"10.1158\/0008-5472.CAN-16-3322","article-title":"Androgens are differentially associated with ovarian cancer subtypes in the ovarian cancer cohort consortium.","volume":"77","author":"Ose","year":"2017","journal-title":"Cancer Res"},{"issue":"9","key":"joi200003r29","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.humpath.2009.04.017","article-title":"Ovarian carcinoma pathology and genetics: recent advances.","volume":"40","author":"Gilks","year":"2009","journal-title":"Hum Pathol"},{"issue":"23","key":"joi200003r30","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers.","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA"},{"issue":"4","key":"joi200003r31","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1097\/GRF.0000000000000318","article-title":"Ovarian cancer prevention in high-risk women.","volume":"60","author":"Temkin","year":"2017","journal-title":"Clin Obstet Gynecol"},{"issue":"5","key":"joi200003r32","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1097\/AOG.0b013e3181a11c64","article-title":"Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses\u2019 health study.","volume":"113","author":"Parker","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"4","key":"joi200003r33","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1097\/AOG.0b013e3182864350","article-title":"Long-term mortality associated with oophorectomy compared with ovarian conservation in the nurses\u2019 health study.","volume":"121","author":"Parker","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"2","key":"joi200003r34","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0301-2115(98)00218-8","article-title":"Differences between hereditary and sporadic ovarian cancer.","volume":"82","author":"Zweemer","year":"1999","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"joi200003r19","doi-asserted-by":"crossref","unstructured":"GWAS results. UK Biobank website. http:\/\/www.nealelab.is\/uk-biobank\/. Updated August 1, 2018. Accessed 15 February, 2019.","DOI":"10.1038\/s41592-018-0245-2"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2761089\/jama_yarmolinsky_2020_oi_200003.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T02:41:26Z","timestamp":1695782486000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2761089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,18]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,2,18]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2020.0150","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2,18]]}}}